Editorial: Antibodies and other biopharmaceuticals

Editorial: Antibodies and other biopharmaceuticals

example in the special issues on biotech in China, Russia and Singapore [4–6]), several aspects of antibodies as therapeutics are addressed in this issue of BTJ. Ruuls et al. review a new class of antibody therapeutics: the age of the Umabs [7]. Zhou et al. review modern production technologies [8] and Garidel et al. report on a rapid, sensitive and economical assessment of monoclonal antibody ...

Production of Biopharmaceuticals, Antibodies and Edible Vaccines in Transgenic Plants

The use of plants and other botanicals as a source of medicines exists of the earliest stages of civilization. Despite great advances in synthetic organic chemistry, it is estimated that about onefourth of present day prescription drugs still have a botanical origin. Recently, and through modern biotechnology, there has been a revival of interest in obtaining new pharmaceuticals from botanical ...

Editorial: Natural Antibodies in Health and Disease

Editorial: Collective responsibility and the other

This issue of CSSE brings together four articles all of which deal with themes that are central to the enterprise of science education. Sonya Martin articulates how she, as a practicing teacher, implemented cogenerative dialogues in her classes, that is, how she implemented a new form of praxis in which teacher and students are provided with opportunities to talk about science curriculum and cl...

Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants.

The use of plants for medicinal purposes dates back thousands of years but genetic engineering of plants to produce desired biopharmaceuticals is much more recent. As the demand for biopharmaceuticals is expected to increase, it would be wise to ensure that they will be available in significantly larger amounts, on a cost-effective basis. Currently, the cost of biopharmaceuticals limits their a...